of prednisolone was reduced to 5 mg daily without relapse. The direct antiglobulin test became negative three months after he started treatment. He has remained well and control of his myasthenia has been unaffected. Thymectomy has not been recommended because of his poor respiratory reserve.
Comment
The relation between myasthenia gravis and thymoma or microscopic hyperplasia of the thymus is well known.' The syndrome of PRCA and thymoma is also well established. Roland2 reviewed 43 cases of the latter and reported the incidence of thymoma in PRCA in adults as 57°h. Six ofthese patients had associated myasthenia gravis and about one-third also had depression of the myeloid or megakaryocyte series, or both. In three patients the thymomas were too small to be shown by radiography and were unsuspected findings at necropsy. Thirty-two of the 43 patients received specific therapy, including thymectomy, thymic irradiation, corticosteroids, androgens, and splenectomy in various combinations: but only one patient had a remission on corticosteroid treatment alone.
There is now much evidence pointing to an autoimmune basis to PRCA,3 and immunosuppressive drugs may be used in treatment, often with (mean 45-5 years) , and all except a 68-year-old woman were men. All had clearly documented gouty arthritis, having been found to have hyperuricaemia and urate crystals in articular aspirate. Most of the patients had normal serum urea (5-51 ±(SE of mean) 0-2 mmol/l (33-2: 1-2 mg/100 ml)) and creatinine (89-7 ±2-3 ,umol/l (1-0±0-03 mg/100 ml)) concentrations, but serum urea was raised in five patients and serum creatinine in three.,We also studied 32 age-and sex-matched controls. None had a history' of joint pain or hypertension or raised serum urea or urate concentrations. A history of known lead exposure was a ground for exclusion in both groups. Serum urate was estimated by a standard automated technique and the blood lead concentration by atomic absorption spectrophotometry using a Perkin Elmer 306 flameless atomic absorption spectrophotometer with HGA 72 graphite-cell power source.
As a group the patients with gout had higher blood lead values than the controls (see table) . For example, none of the gouty subjects had a blood lead concentration of under 0 4 ,umol/l (8-3 ,ug/100 ml), and, whereas only four controls had blood lead concentrations of over 1P5 jsmol/l (31 jug/100 ml)
16 of the patients exceeded this concentration. In only three of the 32 pairs did the control have a blood lead concentration in a higher range than the patient. Reference to the binomial distribution yielded a highly significant result (P< 0-001).
Blood lead concentrations in 32 patients with primary gout and 32 age-and sex-matched controls
Blood lead (p.mol/l): 
Choline is a rate-limiting substrate for the synthesis of acetylcholine by cholinergic nerves. Oral choline increases choline concentrations in plasma and cerebrospinal fluid and also brain acetylcholine and acetylcholine receptor concentrations.2 Its therapeutic effect in chronic tardive dyskinesia is thought to be due to enhanced cholinergic transmission,3 and the same conclusion may tentatively be drawn in the present case. The great improvement on oral choline was abolished by an anticholinergic drug, suggesting that the therapeutic effect was taking place at cholinergic synapses. No improvement was obtained with physostigmine, presumably because anticholinesterases produce only small rises in brain acetylcholine.
The site at which cholinergic transmission was being enhanced is a matter for speculation. Acetylcholine concentrations are low in the cerebellum compared with the rest of the brain.4 The climbing fibre input from the inferior olives may be cholinergic,5 but the evidence is scanty. The site of action may not necessarily be within the cerebellum. The implications of this report are twofold: it suggests that a defect of cholinergic transmission underlies some cerebellar movement disorders; and it offers the possibility of effective treatment for a hitherto untreatable syndrome.
'Kark, R A P, Blass, J P, and Spence, M A, Neurology, 1977, 27, 70 
Case 1
A 29-year-old woman was prescribed penicillin V for a sore throat. Within three minutes after taking the first tablet she developed generalised pruritis and flushing, followed by abdominal cramps, nausea, and one episode of vomiting. When first seen 30 minutes after ingestion, she was responding only to commands and had severe peripheral cyanosis, a tachycardia of 120 beats/min, and blood pressure of 70/50 mm Hg. She was initially treated with 0 5 ml 1/1000 adrenaline subcutaneously, 200 mg hydrocortisone intravenously, and 10 mg chlorpheniramine intravenously, and subsequently with an infusion of hydrocortisone for 12 hours. She regained full consciousness over the next 30 minutes and her blood pressure returned to normal after three hours. On subsequent questioning she admitted having taken penicillin on several previous occasions.
Case 2
A 47-year-old man was prescribed talampicillin for a cough of one week's duration. Thirty minutes after taking the first tablet he developed facial oedema, pruritis, and nausea and then lost consciousness. When first seen at home he was severely cyanosed and was responding only to painful stimuli. He was given 10 mg chlorpheniramine intravenously together with 200 mg hydrocortisone, and a 19-G needle was inserted into his trachea. After transfer to hospital and further treatment with antihistamines and steroids his conscious level and respiration improved but he remained hypotensive for several hours before recovering fully. Subsequently he said that he had taken penicillin preparations on several other occasions with no adverse effects, the last time being three months previously.
Comment
These two patients suffered severe anaphylactic shock after oral ingestion of penicillin and both had been treated with penicillin preparations previously with no symptoms suggestive of allergy. The incidence of anaphylactic shock in all patients treated with penicillin is between 0 015 and 0 040o, with death occurring in 0 002'S of cases.1
Anaphylaxis after oral ingestion is, however, even less common than after parenteral administration, and Batson2 could find only 28 cases in a survey of published reports up to 1960. There have been four reports of fatal anaphylaxis due to oral penicillin preparations.3 Patients who develop anaphylactic reactions have usually been treated with penicillin before-for example, 25 of the 28 patients in Batson's series and three out of four patients quoted by Spark3 had received previous treatment.
The main antigenic stimulus in penicillin allergy is now thought to come from the breakdown products of the penicillin molecule: the penicilloyl group, with the "minor antigenic determinants," such as Na-benzylpenilloate and Na-benzylpenicilloate, being particularly relevant in the development of anaphylactic reactions. Since all semisynthetic forms of penicillin are built around the same molecular nucleus, this accounts for cross-allergy to different preparations, and activation of allergy in already sensitised individuals often requires only minimal amounts of penicillin, particularly with regard to anaphylactic reactions. This was well illustrated by our patients. We want to draw attention to this point and also to the fact that oral penicillin preparations can cause as rapid and as severe an allergic reaction as parenteral preparations.
